Regular snoring becomes more likely as you age. For me, the condition seems to have emerged about five years ago, in my early 30s, although it’s hard to pinpoint the precise beginning because I was ...

Kristian Harloff and Winston A. Marshall react to the final episodes of Demon Slayer Season 1. They experience the storytelling, animation, and unforgettable moments.

BetterSleep helps you build healthier nighttime routines with guided sleep meditations, calming soundscapes, and other proven relaxation techniques.

The CPAP At Home Sleep Test is convenient, easy to use, and might lead to the bedroom upgrade your relationship deserves.

Treating obstructive sleep apnea (OSA) goes beyond improving sleep quality. “Obstructive sleep apnea is not just about snoring or feeling tired — it is very much a brain condition,” says Joanna ...

In less than 90 minutes, a new, less invasive electrical stimulation technique has been found to improve breathing in people with sleep apnea. The technique, which involves percutaneous hypoglossal ...

Bruxism manifests as two distinct circadian rhythms: sleep bruxism and awake bruxism. Obstructive sleep apnea serves as a significant biological trigger for nocturnal grinding. Chronic untreated ...

Sleep apnea is a serious condition, causing breathing to stop and start several times during sleep. The most common form of the condition is obstructive sleep apnea, where the throat narrows, blocking ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Please provide your email address to receive an email when new articles are posted on . A higher proportion of adults with insomnia and sleep apnea had uncontrolled hypertension vs. those with only ...

A new pill could change the landscape for sleep apnea treatment. The condition affects some 30 million Americans, according to the AMA. Currently, the most commonly prescribed treatment is the widely ...

The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...